1. Home
  2. RVLV vs HROW Comparison

RVLV vs HROW Comparison

Compare RVLV & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVLV
  • HROW
  • Stock Information
  • Founded
  • RVLV 2003
  • HROW 1998
  • Country
  • RVLV United States
  • HROW United States
  • Employees
  • RVLV N/A
  • HROW N/A
  • Industry
  • RVLV Catalog/Specialty Distribution
  • HROW Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVLV Consumer Discretionary
  • HROW Health Care
  • Exchange
  • RVLV Nasdaq
  • HROW Nasdaq
  • Market Cap
  • RVLV 1.4B
  • HROW 1.4B
  • IPO Year
  • RVLV 2019
  • HROW N/A
  • Fundamental
  • Price
  • RVLV $22.73
  • HROW $38.89
  • Analyst Decision
  • RVLV Buy
  • HROW Strong Buy
  • Analyst Count
  • RVLV 14
  • HROW 7
  • Target Price
  • RVLV $26.79
  • HROW $64.67
  • AVG Volume (30 Days)
  • RVLV 1000.0K
  • HROW 520.7K
  • Earning Date
  • RVLV 11-04-2025
  • HROW 08-11-2025
  • Dividend Yield
  • RVLV N/A
  • HROW N/A
  • EPS Growth
  • RVLV 38.54
  • HROW N/A
  • EPS
  • RVLV 0.63
  • HROW N/A
  • Revenue
  • RVLV $1,182,554,000.00
  • HROW $227,661,000.00
  • Revenue This Year
  • RVLV $9.12
  • HROW $45.86
  • Revenue Next Year
  • RVLV $6.65
  • HROW $41.41
  • P/E Ratio
  • RVLV $37.70
  • HROW N/A
  • Revenue Growth
  • RVLV 10.68
  • HROW 47.69
  • 52 Week Low
  • RVLV $16.80
  • HROW $20.85
  • 52 Week High
  • RVLV $39.58
  • HROW $59.23
  • Technical
  • Relative Strength Index (RSI)
  • RVLV 54.23
  • HROW 55.37
  • Support Level
  • RVLV $23.03
  • HROW $35.62
  • Resistance Level
  • RVLV $24.29
  • HROW $40.33
  • Average True Range (ATR)
  • RVLV 0.76
  • HROW 1.58
  • MACD
  • RVLV 0.07
  • HROW -0.07
  • Stochastic Oscillator
  • RVLV 53.71
  • HROW 54.35

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: